Desk› Healthcare› Cohance Lifesciences Ltd
Cohance Lifesciences Ltd
Filing rhythm · 61 trading days
26 filings · 4 material · busiest 2026-08-05
What it files
Filings
26 in the window
-
26 August 2026
-
26 August 2026
Annual ReportReg. 34 (1) Annual Report.
Annual Report 2026
Others / Reg. 34 (1) Annual Report View filing →
-
26 August 2026
BRSRBusiness Responsibility and Sustainability Reporting (BRSR)
BRSR
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
13 August 2026
-
12 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
11 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Earnings Call Transcript
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication
Company Update / Newspaper Publication View filing →
-
5 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026
ResultsOutcome Of The Board Meeting
Outcome of the Board Meeting
Result / Financial Results View filing →
-
5 August 2026
GeneralCompletion Of USFDA Inspection
Completion of USFDA Inspection
Company Update / General View filing →
-
5 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Con Call audio link
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026
Board MeetingBoard Meeting Intimation for Considering The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter Ended 30 June 2026
Cohance Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
23 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Results Conference Call
Company Update / Analyst / Investor Meet View filing →
-
23 July 2026
GeneralAllotment Of Equity Shares Pursuant To Exercise Of Stock Options And Grant Of Stock Options To Certain Eligible Employees Of The Company
Allotment of Equity Shares pursuant to exercise of Stock Options and grant of Stock Options to certain eligible employees of the Company
Company Update / General View filing →
-
7 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
26 June 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication
Company Update / Newspaper Publication View filing →
-
26 June 2026
Trading WindowClosure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 June 2026
ClarificationClarification sought from Cohance Lifesciences Ltd
The Exchange has sought clarification from Cohance Lifesciences Ltd on June 24, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
24 June 2026
GeneralClarification On Volume Movement
Clarification on Volume Movement
Company Update / General View filing →
-
19 June 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
19 June 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
19 June 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
18 June 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 June 2026
SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
18 June 2026
SASTDisclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
17 June 2026
ResignationResignation of Director
Resignation of Mr. Himanshu Agarwal as Executive Director and Chief Financial Officer of the Company
Company Update / Resignation of Director View filing →